D-serine treatment for neurological disorders that cause seizures
US10695310B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 25, 2019 |
| Grant date | Jun 30, 2020 |
| Priority date | — |
| Expiry date | Feb 25, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treatment using D-serine to target brain cells expressing GluN3 subunit-containing triheteromeric NMDARs are disclosed. The methods include inhibiting calcium ion uptake by brain cells, treating epilepsy, and treating seizures by artificially administering D-serine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.